中国神经再生研究(英文版)

中国神经再生研究(英文版) ›› 2013, Vol. 8 ›› Issue (15): 1431-1438.doi: 10.3969/j.issn.1673-5374.2013.15.011

• 综述:脑损伤修复保护与再生 • 上一篇    

SCI数据库收录脑胶质瘤干细胞研究的高被引文献分析

  

  • 收稿日期:2013-02-05 修回日期:2013-04-19 出版日期:2013-05-25 发布日期:2013-05-25

The top cited articles on glioma stem cells in Web of Science

Fuxin Yi, Jun Ma, Weimin Ni, Rui Chang, Wenda Liu, Xiubin Han, Dongxiao Pan, Xingbo Liu, Jianwu Qiu   

  1. Department of Neurosurgery, First Affiliated Hospital of Liaoning Medical University, Jinzhou 121000, Liaoning Province, China
  • Received:2013-02-05 Revised:2013-04-19 Online:2013-05-25 Published:2013-05-25
  • Contact: Fuxin Yi☆, M.D., Associate professor, Master’s supervisor, Department of Neurosurgery, First Affiliated Hospital of Liaoning Medical University, Jinzhou 121000, Liaoning Province, China, Yifuxin2007@sina.com.

PDF

941

摘要：

背景：脑胶质瘤是常见的颅内肿瘤，其预后较差。近年来，很多学者关注胶质瘤干细胞的研究，希望能为脑胶质瘤的治疗提供新的方向。
目的：运用文献计量学方法分析SCI数据库收录脑胶质瘤干细胞研究文献的高被引文章。研究其来源国家及机构，来源出版物等情况，并寻找各因素之间的关系。
方法：由第一作者以“glioma stem cell’ or ‘glioma AND "stem cell*’ or “brain tumor stem cell*”为主题词检索SCI数据库以英文发表的关于脑胶质瘤干细胞研究的文章。通过阅读文题及摘要，选取引文次数多于100次的63篇文章。数据下载日期为2013年2月15日。
结果：SCI数据库共收录2 040篇脑胶质瘤干细胞相关文章，被引超过100次的前63篇文章发表于1992-2010年期间。最高被引1 754次，63篇文章的平均被引280次，来源于19个国家，其中美国发表文章最多，有46篇。美国杜克大学和旧金山加利福尼亚大学各发表7篇文章。63篇文章发表在28本期刊中，以《肿瘤研究》及《肿瘤细胞》杂志发表的文献排在首位，其次为《细胞干细胞》和《科学》杂志。
结论：在脑胶质瘤干细胞研究文献中，来源于美国优秀学术机构作者发表的文章及发表在影响因子较高期刊的文章容易出现受读者喜欢的高被引现象。

关键词: 神经再生, 脑胶质瘤, 康复, 治疗, Web of Science, 干细胞, 引文分析, 系统回顾

Abstract:

BACKGROUND: Glioma is the most common intracranial tumor and has a poor patient prognosis. The presence of brain tumor stem cells was gradually being understood and recognized, which might be beneficial for the treatment of glioma.
OBJECTIVE: To use bibliometric indexes to track study focuses on glioma stem cell, and to investigate the relationships among geographic origin, impact factors, and highly cited articles indexed in Web of Science.
METHODS: A list of citation classics for glioma stem cells was generated by searching the database of Web of Science-Expanded using the terms “glioma stem cell” or “glioma, stem cell’” or “brain tumor stem cell”. The top 63 cited research articles which were cited more than 100 times were retrieved by reading the abstract or full text if needed. Each eligible article was reviewed for basic information on subject categories, country of origin, journals, authors, and source of journals. Inclusive criteria: (1) articles in the field of glioma stem cells which was cited more than 100 times; (2) fundamental research on humans or animals, clinical trials and case reports; (3) research article; (4) year of publication: 1899–2012; and (5) citation database: Science Citation Index-Expanded. Exclusive criteria: (1) articles needing to be manually searched or accessed only by telephone; (2) unpublished articles; and (3) reviews, conference proceedings, as well as corrected papers.
RESULTS: Of 2 040 articles published, the 63 top-cited articles were published between 1992 and 2010. The number of citations ranged from 100 to 1 754, with a mean of 280 citations per article. These citation classics came from nineteen countries, of which 46 articles came from the United States. Duke University and University of California, San Francisco led the list of classics with seven papers each. The 63 top-cited articles were published in 28 journals, predominantly Cancer Research and Cancer Cell, followed by Cell Stem Cell and Nature.
CONCLUSION: Our bibliometric analysis provides a historical perspective on the progress of glioma stem cell research. Articles originating from outstanding institutions of the United States and published in high-impact journals are most likely to be cited.